Childhood Tuberculosis Contact Investigation and Treatment of Latent Tuberculosis Infection: a Single Center Study, 2014-2017 |
Hwang, Woo Jin
(Department of Pediatrics, Chungnam National University Hospital)
Lee, Go Un (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University Hospital) Kim, So Hyun (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University Hospital) Cho, Eun Young (Department of Pediatrics, Chungnam National University Hospital) |
1 | Joint Committee for the Revision of Korean Guidelines for Tuberculosis; The Korean Academy of Tuberculosis and Respiratory Diseases; Korea Centers for Disease Control and Prevention. National Tuberculosis Control Program. In: Korean guidelines for tuberculosis, 3rd ed [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2017 [cited 2018 Oct 22]: 219-21. Available from: http://www.cdc.go.kr/CDC/together/CdcKrTogether0302.jsp?menuIds=HOME006-MNU2804-MNU3027-MNU2979&cid=138077. |
2 | Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Nelson LJ, et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8:278-85. |
3 | Joint Committee for the Revision of Korean Guidelines for Tuberculosis; The Korean Academy of Tuberculosis and Respiratory Diseases; Korea Centers for Disease Control and Prevention. Tuberculosis in children and adolescents. In: Korean guidelines for tuberculosis, 3rd ed [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2017 [cited 2018 Oct 22]: 122-57. Available from: http://www.cdc.go.kr/CDC/together/CdcKrTogether0302.jsp?menuIds=HOME006-MNU2804-MNU3027-MNU2979&cid=138077. |
4 | Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8:392-402. |
5 | Kim JH, Yim JJ. Achievements in and challenges of tuberculosis control in South Korea. Emerg Infect Dis 2015;21:1913-20. DOI |
6 | World Health Organization. BOX 1.1. Basic facts about TB & Chapter 1. Introduction. In: Global tuberculosis report 2018 [Internet]. Geneva: World Health Organization; 2018 [cited 2018 Oct 22]: 6-7. Available from: https://www.who.int/tb/publications/global_report/en. |
7 | Lee TJ, Kim EK, Jeong HC. Outcomes of child contact investigations of active pulmonary tuberculosis patients: a single center experience from 2012 to 2014. Pediatr Infect Vaccine 2015;22:91-6. DOI |
8 | Korea Centers for Disease Control and Prevention. 2018 National tuberculosis program guideline [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2018 [cited 2018 Oct 22]. Available from: http://www.cdc.go.kr/CDC/together/CdcKrTogether0302.jsp?menuIds=HOME006-MNU2804-MNU3027-MNU2979&cid=138005. |
9 | Joint Committee for the Revision of Korean Guidelines for Tuberculosis. Korean guidelines for tuberculosis, 2nd edition [Internet]. Cheongju: Korea Centers for Disease Control and Prevention; 2014 [cited 2018 Oct 22]. Available from: http://www.cdc.go.kr/CDC/together/CdcKrTogether0302.jsp?menuIds=HOME006-MNU2804-MNU3027-MNU2979&cid=138235. |
10 | Lee MH, Sung JJ, Eun BW, Cho HK. Survey of secondary infections within the households of newly diagnosed tuberculosis patients. Pediatr Infect Vaccine 2015;22:7-15. DOI |
11 | Min DH, Wy HH, Shim JW, Kim DS, Jung HL, Park MS, et al. Risk factors for latent tuberculosis in children who had close contact to households with pulmonary tuberculosis. Allergy Asthma Respir Dis 2017;5:105-10. DOI |
12 | Frydenberg AR, Graham SM. Toxicity of first-line drugs for treatment of tuberculosis in children: review. Trop Med Int Health 2009;14:1329-37. DOI |
13 | Ena J, Valls V. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis 2005;40:670-6. DOI |
14 | Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, Coberly JS, et al. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. Am J Respir Crit Care Med 2006;173:922-6. DOI |
15 | World Health Organization. TABLE A4.1. TB incidence estimates, 2017 & TABLE A4.2. Estimates of TB mortality, 2017. In: Global tuberculosis report 2018 [Internet]. Geneva: World Health Organization; 2018 [cited 2018 Oct 22]: 245-52. Available from: https://www.who.int/tb/publications/global_report/en. |
16 | Spyridis NP, Spyridis PG, Gelesme A, Sypsa V, Valianatou M, Metsou F, et al. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis 2007;45:715-22. DOI |